Patient characteristics | Pre-intervention period (n = 47) | Intervention period (n = 48) | p value |
---|---|---|---|
Age (years) | 61 (44.5–66) | 60.5 (54–67.25) | 0.099 |
Sex (female), n (%) | 26 (55) | 18 (38) | 0.082 |
Underlying hematologic disease, n (%) | Â | Â | 0.065 |
 Acute myeloid leukemia | 22 (47) | 29 (61) |  |
 Acute lymphoblastic leukemia | 3 (6) | 0 (0) |  |
 Multiple myeloma | 7 (15) | 5 (10) |  |
 Lymphoma | 9 (20) | 2 (4) |  |
 Myelodysplastic syndrome | 3 (6) | 3 (6) |  |
 Myelofibrosis | 2 (4) | 5 (10) |  |
 Other | 1 (2) | 4 (9) |  |
Charlson Comorbidity Index | 4 (3–4) | 4 (3–5) | 0.126 |
Colonization with MDR bacteria, n (%) | 5Â (11) | 3Â (6) | 0.486 |
Admission characteristics | Pre-intervention period (n = 56) | Intervention period (n = 57) | p value |
Reason for admission, n (%) | Â | Â | 0.095 |
 Induction | 14 (25) | 26 (46) |  |
 Consolidation | 8 (14) | 4 (7) |  |
 Conditioning for autologous HSCT | 11 (20) | 6 (10) |  |
 Conditioning for allogeneic HSCT | 22 (39) | 21 (37) |  |
 Microtransplantation | 1 (2) | 0 (0) |  |
Duration of neutropenia (days) | 14 (10–22) | 18 (13–24) | 0.121 |